Paul Graves - Publications

Pharmacology Duke University, Durham, NC 

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Graves PR, Aponte-Collazo LJ, Fennell EMJ, Graves AC, Hale AE, Dicheva N, Herring LE, Gilbert TSK, East MP, McDonald IM, Lockett MR, Ashamalla H, Moorman NJ, Karanewsky DS, Iwanowicz EJ, et al. Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogs. Acs Chemical Biology. PMID 31021596 DOI: 10.1021/Acschembio.9B00222  0.321
2013 Deb S, Graves PR. Identification of novel mutant p53 interacting proteins by proteomic analysis. Methods in Molecular Biology (Clifton, N.J.). 962: 85-94. PMID 23150439 DOI: 10.1007/978-1-62703-236-0_7  0.416
2008 Zeng Y, Sankala H, Zhang X, Graves PR. Phosphorylation of Argonaute 2 at serine-387 facilitates its localization to processing bodies. The Biochemical Journal. 413: 429-36. PMID 18476811 DOI: 10.1042/BJ20080599  0.308
2007 Higgins MJ, Graves PR, Graves LM. Regulation of human cytidine triphosphate synthetase 1 by glycogen synthase kinase 3 Journal of Biological Chemistry. 282: 29493-29503. PMID 17681942 DOI: 10.1074/jbc.M703948200  0.314
2007 Walker JR, Gnanam AJ, Blinkova AL, Hermandson MJ, Karymov MA, Lyubchenko YL, Graves PR, Haystead TA, Linse KD. Clostridium taeniosporum spore ribbon-like appendage structure, composition and genes. Molecular Microbiology. 63: 629-43. PMID 17302797 DOI: 10.1111/J.1365-2958.2006.05494.X  0.535
2005 Graves PR, Winkfield KM, Haystead TA. Regulation of zipper-interacting protein kinase activity in vitro and in vivo by multisite phosphorylation. The Journal of Biological Chemistry. 280: 9363-74. PMID 15611134 DOI: 10.1074/Jbc.M412538200  0.598
2003 Graves PR, Haystead TA. A functional proteomics approach to signal transduction. Recent Progress in Hormone Research. 58: 1-24. PMID 12795412 DOI: 10.1210/Rp.58.1.1  0.611
2003 Bulavin DV, Higashimoto Y, Demidenko ZN, Meek S, Graves P, Phillips C, Zhao H, Moody SA, Appella E, Piwnica-Worms H, Fornace AJ. Dual phosphorylation controls Cdc25 phosphatases and mitotic entry. Nature Cell Biology. 5: 545-51. PMID 12766774 DOI: 10.1038/Ncb994  0.407
2002 Graves PR, Kwiek JJ, Fadden P, Ray R, Hardeman K, Coley AM, Foley M, Haystead TA. Discovery of novel targets of quinoline drugs in the human purine binding proteome. Molecular Pharmacology. 62: 1364-72. PMID 12435804 DOI: 10.1124/Mol.62.6.1364  0.345
2002 Graves PR, Haystead TA. Molecular biologist's guide to proteomics. Microbiology and Molecular Biology Reviews : Mmbr. 66: 39-63; table of cont. PMID 11875127 DOI: 10.1128/Mmbr.66.1.39-63.2002  0.598
2001 Graves PR, Lovly CM, Uy GL, Piwnica-Worms H. Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding. Oncogene. 20: 1839-51. PMID 11313932 DOI: 10.1038/Sj.Onc.1204259  0.419
1998 Thorson JA, Yu LW, Hsu AL, Shih NY, Graves PR, Tanner JW, Allen PM, Piwnica-Worms H, Shaw AS. 14-3-3 proteins are required for maintenance of Raf-1 phosphorylation and kinase activity. Molecular and Cellular Biology. 18: 5229-38. PMID 9710607 DOI: 10.1128/Mcb.18.9.5229  0.303
1997 Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science (New York, N.Y.). 277: 1501-5. PMID 9278512 DOI: 10.1126/Science.277.5331.1501  0.389
Show low-probability matches.